Health Canada drug identification number

DIN 02449552 — AURO-ZIPRASIDONE 40 MG

AURO-ZIPRASIDONE is a capsule of Ziprasidone marketed by AURO PHARMA INC. The full Ziprasidone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02449552
Brand name
AURO-ZIPRASIDONE
Active ingredient
Ziprasidone
Strength
40 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
AURO PHARMA INC
Health Canada status
MARKETED
Drug class
Atypical (second-generation) antipsychotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ziprasidone products

DINBrandStrengthFormManufacturerStatus
02449544 AURO-ZIPRASIDONE 20 MG CAPSULE AURO PHARMA INC MARKETED
02449560 AURO-ZIPRASIDONE 60 MG CAPSULE AURO PHARMA INC MARKETED
02449579 AURO-ZIPRASIDONE 80 MG CAPSULE AURO PHARMA INC MARKETED
02298597 ZELDOX 20 MG CAPSULE BGP PHARMA ULC MARKETED
02298600 ZELDOX 40 MG CAPSULE BGP PHARMA ULC MARKETED
02298619 ZELDOX 60 MG CAPSULE BGP PHARMA ULC MARKETED
02298627 ZELDOX 80 MG CAPSULE BGP PHARMA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.